Incorrect Labeling of Drugs Sent to Hospital Inpatient Pharmacies

Aidapak Services LLC is conducting a voluntary recall of specific unit dose repackaged products sent to 25 hospital inpatient pharmacies in the states of Washington, Oregon, California, and Arizona. These products were recalled to the hospital/user level after learning of possible incorrect labeling which could involve over the counter, prescription, and dietary supplement products.


Some of the products, if incorrectly labeled, could result in patients receiving drugs that were not prescribed, which could result in allergic reactions or other undesired effects. Pregnant women could receive a drug that they should not take or, as a result of receiving an incorrect medication, patients may not receive proper treatment of their disease or condition. This may pose serious or life-threatening risk to a patient’s health.


Products affected by this recall are limited to strip packs packaged between May 1, 2013, and July 1, 2013, in single-use dosage form, intended specifically to be administered to hospital patients while admitted to the hospital.


All products affected by this recall are stamped with AidaPak’s packaging stamp. Products not stamped with AidaPak’s packaging stamp are not affected by this recall.


See the Recall


See also Medical Law Perspectives, May 2013 Report: Drugs, Dosage, and Damage: Physician Liability for Prescribing or Administering Medication